FDA Approves Crinecerfont for Congenital Adrenal Hyperplasia
HCPLive
DECEMBER 13, 2024
Crinecerfont is indicated to be used with glucocorticoids to control androgen levels in adults and pediatric patients with classic congenital adrenal hyperplasia.
Researchers Link Infant Heart Defects, Childhood Cancer
DAIC
MARCH 17, 2025
are forms of congenital heart defects (CHD). about 12 infants in 1,000 births have a congenital heart defect, according to the Associations 2025 Heart Disease and Stroke Statistics. Researchers have yet to determine why having a baby with a congenital heart defect is associated with a higher risk for cancer in mothers.
Cancer 
52
52 
Congenital Heart Futures Reauthorization Act 2024
Conquering CHD
FEBRUARY 1, 2024
History of the Congenital Heart Futures Act First passed into law in 2010, the bipartisan Congenital Heart Futures Act was groundbreaking legislation authorizing research and data collection specific to Congenital Heart Disease. Raising awareness of CHD through the lifespan.
Congenital 98
98 
Ochsner Children’s Hospital Advocates to Close the Gap in Pediatric Heart Care
DAIC
FEBRUARY 21, 2024
Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. For three consecutive years, U.S.
Pediatrics 105
105 
Hot Topics in Congenital and Pediatric Cardiology in the Year 2023
American College of Cardiology
DECEMBER 19, 2023
This year saw exciting developments in the treatment of pediatric and congenital heart disease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.
Congenital 70
70 
The impact of pre-transplant ventricular assist device support in pediatric patients with end-stage heart failure on the outcomes of heart transplantation—“a single center experience”
Frontiers in Cardiovascular Medicine
JANUARY 22, 2025
In light of the limited availability of donor organs, particularly in Europe, the number of children requiring ventricular assist device support is rising at an unavoidable rate.MethodsWe performed a retrospective cohort study of patients who underwent a single and primary pediatric heart transplantation.
Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients
DAIC
MARCH 6, 2024
Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
Pediatrics 105
105 
Cardiopulmonary Exercise Test Interpretation Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association
Journal of the American Heart Association
JANUARY 9, 2025
Survivorship from congenital heart disease has improved rapidly secondary to advances in surgical and medical management. The purpose of this statement is to provide a lifespan approach to the interpretation of cardiopulmonary exercise testing in patients with congenital heart disease.
Case Report: A new therapeutic option for a rare patent ductus arteriosus child complicated with pulmonary artery aneurysm due to infectious endocarditis
Frontiers in Cardiovascular Medicine
FEBRUARY 18, 2025
Patent ductus arteriosus (PDA) is one of the most common forms of congenital heart disease (CHD). In this report, we report a rare pediatric PDA case, complicated with PAA due to IE. Infectious endocarditis (IE) is a rare but serious complication of PDA. PDA combined with pulmonary artery aneurysm (PAA) due to IE is rare in children.
Aneurysm 52
52 
Congenital and Pediatric Care
Society of Thoracic Surgeons - Adult Cardiac
FEBRUARY 5, 2024
Congenital and Pediatric Care gtrainyte Mon, 02/05/2024 - 11:14 Scroll to top STS recognizes the important role of congenital and pediatric specialists. Congenital heart defects (CHDs) are the most common types of birth defects, and babies born with these conditions are living longer and healthier lives.
Pediatrics 40
40 
Overcoming the Odds with Expert Fetal Cardiology Care: Zeke and Zane’s Story
Conquering CHD
JANUARY 17, 2025
As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. At their first appointment, the family met with a complete team of fetal and pediatric heart specialists, maternal fetal medicine experts, genetic counselors and other doctors to review and confirm Zanes diagnosis.
Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System
DAIC
JANUARY 6, 2025
6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). 1 Hoffman JL, Kaplan S.
Pulmonary 52
52 
A heart valve that grows with a pediatric patient
Medical Xpress - Cardiology
DECEMBER 13, 2023
A prototype of an expanding artificial heart valve could make a big dent in the number of surgeries that many kids born with congenital heart disease need.
Heart Valves 94
94 
Impact of Heart Transplant Allocation Changes on Waitlist Mortality and Clinical Practice in Pediatric and Adult Patients With Congenital Heart Disease and Cardiomyopathy
Circulation
JANUARY 9, 2025
BACKGROUND:The United Network of Organ Sharing made changes to the priority for allocation of hearts for transplantation (HT) in 2016 for pediatric patients and 2018 for adult patients. Children with cardiomyopathy and adults with CHD did not experience the mortality benefits experienced by adults with cardiomyopathy and children with CHD.
Cognitive biases in pediatric cardiac care
Frontiers in Cardiovascular Medicine
JULY 5, 2024
As pediatric cardiologists, we frequently confront emergencies necessitating rapid decision-making, while contending with the pressures of stress, fatigue, an earnest interest in “doing the right thing” and the impact of parental involvement.
Pediatrics 52
52 
Children's National, med device company partner on pediatric heart tech
Becker's Hospital Review - Cardiology
FEBRUARY 13, 2025
-based Children's National Hospital has partnered with medical device company Compremium AG to help develop new technologies designed for pediatric patients. The partnership will first focus on noninvasive monitoring of central venous pressure for congenital heart disease patients.
Pediatrics 52
52 
Aneurysm and subacute type a aortic dissection, in a pediatric patient with aortopathy
Journal of Cardiothoracic Surgery
FEBRUARY 19, 2025
Aortic dissection in pediatrics is an extremely rare condition, which is generally related to predisposing factors such as connective tissue disorders, congenital heart disease and systemic arterial hypertensi.
Pediatrics 52
52 
Pediatric Exercise Testing
All About Cardiovascular System and Disorders
MARCH 25, 2024
Discussion on pediatric exercise testing. Pediatric exercise testing may be used for evaluation of various disorders of cardiac rhythm rather than for inducible ischemia as in adults. ECG showing congenital complete heart block with ventricular rate of 47/min and atrial rate of 63/min.
Exercise 52
52 
Pediatric Specialists May Receive $100,000 in Student Loan Forgiveness
Society of Thoracic Surgeons - Adult Cardiac
JULY 12, 2023
citizen, national, or permanent resident; meet educational and credential requirements; and either be employed or begin training as a pediatric specialist at a PSLRP-approved site serving a medically underserved area or population. This program invests in current and future pediatric cardiothoracic surgeons to meet the growing demand.
Pediatrics 52
52 
Multicenter retrospective evaluation of magnetic resonance imaging in pediatric and congenital heart disease patients with cardiac implantable electronic devices
HeartRhythm
AUGUST 27, 2023
Guidelines addressing magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIEDs) provide algorithms for imaging pediatric and congenital heart disease (CHD) patients. Guideline acceptance varies by institution.
Absorbable metal stents for vascular use in pediatric cardiology: progress and outlook
Frontiers in Cardiovascular Medicine
JULY 25, 2024
Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heart disease (CHD). We also discuss the challenges and our center's experience associated with the use of absorbable metal stents in this pediatric population.
Stent 52
52 
Expert explains how new pediatric heart surgery guidelines will impact care
Medical Xpress - Cardiology
FEBRUARY 1, 2024
undergo congenital heart surgery. Every year, more than 40,000 patients in the U.S. But across centers, studies have shown that there can be significant variations in outcomes for these patients.
Pediatrics 71
71 
Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry
Frontiers in Cardiovascular Medicine
FEBRUARY 2, 2024
Aims A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification. The role of ASD in pediatric PH should be reconsidered. No survival difference could be demonstrated between the groups.
Congenital Heart Defects: Helping Families Navigate the Challenges
MIBHS
SEPTEMBER 30, 2024
Congenital heart defects (CHDs) are the most common type of birth defect, affecting nearly 1 in 100 newborns. Understanding Congenital Heart Defects A congenital heart defect refers to a problem with the structure of the heart that is present at birth. These structural abnormalities of the heart are present at birth.
Congenital 52
52 
Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association
Circulation
AUGUST 12, 2024
Pathogeneses include connective tissue disorders, smooth muscle contraction disorders, and congenital heart disease, including bicuspid aortic valve, among others. The most common causes of pediatric aortopathy are reviewed. The American Heart Association has published guidelines for diagnosis and management of thoracic aortic disease.
Pediatrics 81
81 
2023: The Year in Review From An ACPC Perspective
American College of Cardiology
JANUARY 2, 2024
As we welcome 2024, the Adult Congenital and Pediatric Cardiology (ACPC) section of the American College of Cardiology continues to celebrate remarkable progress.
Pediatrics 68
68 
New Research Finds Volume Alone Does Not Predict Quality Outcomes in Pediatric Cardiac Surgery
DAIC
JANUARY 30, 2024
Getty Images milla1cf Tue, 01/30/2024 - 20:08 January 30, 2024 — A study of pediatric heart surgery centers across the United States has demonstrated that, when it comes to successful surgery, it’s not just the size of the program that matters in determining quality outcomes. Tweddell Memorial Paper in Congenital Surgery.
Pediatrics 52
52 
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease
Journal of the American Heart Association
FEBRUARY 13, 2024
Management of these complications with standard‐of‐care treatment is suboptimal for these children.Methods and ResultsThe effectiveness and safety of dabigatran were demonstrated in pivotal pediatric studies for the treatment of acute venous thromboembolism (VTE; NCT01895777) and secondary VTE prevention (NCT02197416).
Pediatric cardiac physicians group joins BayCare
Becker's Hospital Review - Cardiology
DECEMBER 9, 2024
Cardiologists from Pediatrix Cardiology Associates and the Tampa Bay Adult Congenital Heart Center have joined Clearwater, Fla.-based based BayCare Health System's physician practice, BayCare Medical Group.
Pediatrics 52
52 
Mortality Patterns in Pediatric Pulmonary Vein Stenosis: Insights Into Right Ventricular Systolic Pressure Associations
Journal of the American Heart Association
JANUARY 17, 2025
P=0.032), and the presence of congenital heart disease (HR, 2.4 [95% The final predictive model for mortality included RV systolic pressure greater than half systemic pressure (HR, 4.0 [95% 95% CI, 1.610.4];P=0.004), P=0.004), moderately or severely diminished RV systolic function (HR, 3.6 [95% 95% CI, 1.111.5];P=0.032), 95% CI, 0.96.7];P=0.084).ConclusionsThis
Stenosis 76
76 Children's hospital advocates to close the gap in pediatric heart care
Medical Xpress - Cardiology
FEBRUARY 21, 2024
Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices.
Pediatrics 40
40 
Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory From the American Heart Association
Circulation
MARCH 28, 2024
Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Challenges related to the use of wearables are common to every clinical setting, but specific topics for consideration in congenital heart disease are highlighted.
Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association
Circulation
MAY 29, 2024
With continued medical and surgical advancements, most children and adolescents with congenital heart disease are expected to survive to adulthood.
And That's a Wrap! ACC.24: An ACPC Perspective
American College of Cardiology
APRIL 29, 2024
24), building on the successes and lessons of past gatherings, marked a significant return to in-person collaboration and learning for the Adult Congenital and Pediatric Cardiology (ACPC) community. The American College of Cardiology Scientific Sessions 2024 (ACC.24),
Pediatrics 60
60 Promising results of a clinical feasibility study: CIRBP as a potential biomarker in pediatric cardiac surgery
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Systemic inflammatory response syndrome (SIRS) and capillary leak syndrome (CLS) are frequent complications after pediatric cardiac surgery increasing morbidity, therefore early diagnosis and therapy is crucial. To our knowledge this is the first clinical study to assess CIRBP serum concentrations in a pediatric population.
Pediatrics 49
49 
Systematic approach to obtain axillary arterial access for pediatric heart catheterizations
Frontiers in Cardiovascular Medicine
JANUARY 30, 2024
Background Axillary arterial access (AAA) in pediatric heart catheterizations is undervalued. Methods We retrospectively reviewed children with congenital heart diseases (CHDs) who received trans-axillary arterial catheterizations between January 2019 and February 2023.
Pediatrics 49
49 
Teen Topics – The Top 10 Things to Remember About CHD as an Adult
Conquering CHD
MARCH 7, 2024
This can be an especially trying time in the life of an adolescent with congenital heart disease, especially as they are undergoing the major transition of leaving the nest and going off to college, joining the workforce, or just moving far from home. This post was originally published in November 2017.
Catheterization for Congenital Heart Disease Adjustment for Risk Method II
Circulation: Cardiovascular Interventions
JANUARY 23, 2024
BACKGROUND:Current metrics used to adjust for case mix complexity in congenital cardiac catheterization are becoming outdated due to the introduction of novel procedures, innovative technologies, and expanding patient subgroups. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers.
Society of Cardiovascular Computed Tomography Annual Scientific Meeting SCCT24 Preview
DAIC
JUNE 27, 2024
Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics. for all attendees.
Peyton Manning, Cincinnati Children's hospitals name heart surgery leader
Becker's Hospital Review - Cardiology
OCTOBER 24, 2024
Vincent have jointly appointed Roosevelt Bryant III, MD, chief of pediatric and congenital heart surgery. Cincinnati Children's and Indianapolis-based Peyton Manning Children's Hospital at Ascension St.
Hospital 52
52 
Early Experience with Ivabradine for Focal Atrial Tachycardia in Pediatric Patients with Congenital Heart Disease
HeartRhythm
OCTOBER 15, 2023
However, current experience using ivabradine for FAT in children is limited to small case series, often not involving congenital heart disease (CHD) patients.(1, Ivabradine’s high selectivity and minimal side effects make it an attractive candidate for wider applications such as focal atrial tachycardia (FAT).
Christ Hospital, Cincinnati Children's partner on heart clinic
Becker's Hospital Review - Cardiology
FEBRUARY 6, 2025
Cincinnati Children's and the Christ Hospital Health Network, also in Cincinnati, have partnered on a clinic to address the needs of patients with congenital heart disease as they age out of pediatric care.
The mechanics of congenital heart disease: from a morphological trait to the functional echocardiographic evaluation
Frontiers in Cardiovascular Medicine
APRIL 7, 2024
Advances in pediatric cardiac surgery have resulted in a recent growing epidemic of children and young adults with congenital heart diseases (CHDs). In these patients, congenital defects themselves, surgical operations and remaining lesions may alter cardiac anatomy and impact the mechanical performance of both ventricles.
FDA Commissioner, Host of Cardiovascular Leaders to Offer Keynote Addresses at ACC.24
DAIC
MARCH 7, 2024
McNamara Keynote Unlocking the Diversity Key in the Pediatric and Adult Congenital Heart Disease Workforce Saturday, April 6, Noon – 1:15 p.m. Isabel-Jones, MD , Professor Emeritus of Pediatrics, UCLA Health. From Civil Rights to Patient Equity — A Legacy of Strength” Presented by Josephine B.
Let's personalize your content